Transforming growth factor- (TGF-) is a cytokine that plays various functions in the control of Trypanosoma cruzi infectivity and in the progression of Chagas disease. When we immunostained Trypanosoma cruzi-infected cardiomyocytes (following either in vivo or in vitro infections) for TGF-, we observed stronger immunoreactivity in parasites than in host cells. TGF- immunoreactivity evolved during parasite cycle progression: intense staining in amastigotes versus very faint staining in trypomastigotes. TGF- was present on the surface of amastigotes, in the flagellar pocket and in intraparasitic vesicles as revealed by electron microscopy. However, no ortholog TGF- gene could be identified in the genome of Trypanosoma cruzi by in silico analysis or by extensive PCR and RT-PCR studies.
Introduction

Chagas disease is a human disease caused by infection with the flagellate parasite
Trypanosoma cruzi (T. cruzi) which affects about 15 million people in Latin America 1 .
Infective non-replicative trypomastigote forms of the parasites circulate periodically in the blood of chronic patients whereas proliferative intracellular amastigotes persist in tissues 2 .
Heart damage and dysfunction are important features in patients with chronic Chagas disease and numerous studies are conducted to elucidate the physiopathology of this disease 3 . A role for parasite antigens has been proposed to explain the development of extensive fibrosis that is characteristic of the cardiac form of Chagas disease 4 . We previously reported that circulating levels of Transforming Growth Factor-1 (TGF-1) are increased in patients with the cardiac form of Chagas disease 5 . In addition, we observed a contrasting pattern of fibronectin and phosphorylated Smad 2 (an intracellular signal-transducing protein phosphorylated by activated TGF- receptors) immunoreactivity in the hearts of patients with Chagasic cardiopathy 5 , indicating that the TGF- signaling pathway is highly active in these patients. All these observations point to a functional link between TGF-1 and the parasite T.
cruzi in the etiology of Chagasic myocardiopathy.
TGF- is the prototypic member of a family of polypeptidic growth and differentiation factors which play a great variety of biological functions in such diverse processes as inflammation, fibrosis, immunosuppression, cell proliferation, cell differentiation and cell death [6] [7] [8] . Virtually all cells synthesize and secrete TGF- as a biologically inactive protein complex termed latent TGF-, which is stored in the pericellular environment. Latent TGF- activation results from different enzymatic and non-enzymatic mechanisms 9 and only the active form of TGF- can interact with the specific transmembrane TGF- receptors at the cell surface, inducing cell signaling and biological responses. TGF-has already been implicated in three important processes associated with Chagas disease: (a) stimulation of fibrosis 5, 10 ; (b) parasitic cell invasion 11, 12 ; (c) down-regulation of cellular and immune mechanisms of parasite control 13, 14 . During the course of our studies on the regulation of fibrosis during T. cruzi infection 10 , an interesting observation was made: immunolabeling of infected cardiomyocytes using a polyclonal antiserum against human TGF- revealed immunoreactivity in the intracellular amastigote forms of T. cruzi. In the present work, we further documented this observation and addressed the question of the origin of this intraparasitic TGF-. Did it result from synthesis by the parasite or was it taken up from the host cell cytoplasm? Our results indicated that the parasite is able to internalize host cell TGF-, to accumulate it during its intracellular proliferation phase and suggested that it may use it as a signaling mediator to trigger differentiation into trypomastigote. So, like for various other species, TGF-appears as a regulator of the developmental events driving T. cruzi life cycle.
Materials and Methods
In situ immunohistochemical staining: Paraffin-embedded myocardial sections (5 m)
were obtained from T. cruzi-infected mice as described elsewhere 10 . Sections were incubated in 10mM citrate buffer and microwaved for 2 x 10 minutes, followed by saturation for 1 hour at room temperature with 5% normal goat serum in TBS-BSA (Tris-buffered saline/ 1% bovine serum albumin). Sections were double stained with anti-human TGF- antibody (AB-100-NA, R&D Systems, Oxon, UK) 1:50 and 4,6-diamidino-2-phenylindole (DAPI, Sigma, St Louis, MO) 1:5000. After 3 washes with TBS-BSA, secondary FITC-conjugated goat antirabbit IgGs (Jackson Laboratories, West Grove, PA) were added at 1:100 for 1 hour at room temperature.
In vitro T. cruzi-heart cell infection: Mouse embryo cardiomyocytes were obtained and grown in primary culture as previously described 15 . Briefly, cells were seeded in 24-well plates, incubated for 24 hours at 37°C in a 5% CO 2 
Amastigogenesis in vitro:
The infective trypomastigote forms of T. cruzi Y strain were obtained from the blood of infected mice at the peak of parasitaemia. In all assays, the living parasites were incubated in serum-free medium. The multiplicative amastigote forms were obtained 24 and 48 hours after acid induction as previously described 16 , and counted in a Neubauer chamber.
In vitro proliferation of amastigotes: After 4hours of acid induction, amastigotes (10 6 /ml)
were incubated with 10 ng/ml of recombinant TGF-1 (Promega). 24 hours and 48 hours later, the live parasites were counted in each sample in a Neubauer hematimeter.
TGF-binding to amastigotes in vitro:
The multiplicative amastigote forms were obtained 48 hours after acid induction as previously described 16 . 0. 
Results
Presence of TGF- immunoreactivity in intracellular amastigotes:
We previously reported that the TGF- signaling pathway is activated in the infected hearts of human patients with Chagasic cardiomyopathy 5 . In order to better understand this mechanism, we wondered whether TGF- was detectable in the hearts of T. cruzi-infected mice. The analysis was performed on day 22 post-infection, when the parasites have infected various tissues including the heart 10 . To our surprise, using a pan-specific polyclonal anti-TGF- antibody that recognizes mammalian TGF-1 and TGF-2 as well as Xenopus TGFwe observed that TGF- immunoreactivity was more intense on intracellular parasites (essentially amastigotes) than in the cytoplasm of cardiomyocytes ( taken on infected cardiomyocytes along the z axis ( Fig 2D) . This allowed us to confirm that the stained vesicular structures were inside the parasite rather than on its surface.
To better explore these aspects, electron microscope immunolabeling was performed on lowicryl-embedded sections of parasitized cardiomyocytes using immunogold particles and anti-TGF- antibodies (Fig. 3 A, B) . In all 38 EM images that were generated, gold particles could be seen on the surface, in the flagellar pocket (fp), and in granules (g) of amastigotes. TGF- thus appeared to be localized in the endocytic/exocytic parasite machinery.
Absence of a TGF- ortholog gene in the T. cruzi genome:
These intriguing observations suggested two possibilities concerning the origin of TGF- immunoreactivity. Either a TGF--like molecule is synthesized by the parasite and its sequence is sufficiently conserved to be recognized by both polyclonal and monoclonal antivertebrate TGF- antibodies, or mammalian TGF- is taken up by the intracellular parasites from the host cells.
We first tried to address the question of the possible existence of a TGF- gene in the T. cruzi genome. Members of the TGF- superfamily of growth and differentiation factors have been identified in a wide variety of organisms, ranging from invertebrates to mammals 6, [17] [18] [19] , and the existence of molecular mimicry between T. cruzi and mammalian hosts 20 suggested that a TGF- ortholog might exist in the T. cruzi genome. Conserved peptide motifs throughout TGF- proteins, spanning species from nematodes to human, were identified. We chose to study four such motifs from the N-terminal part, and four motifs from the C-terminal part, corresponding to the least amount of degenerate codon possibilities. Next, using a T.
cruzi specific codon table, non-degenerate primers were designed corresponding to the selected sequences. In this way, 4 forward primers and 4 reverse primers were synthesized and used in different combinations so as to amplify potential TGF- gene fragments by PCR on T. cruzi genomic DNA, since the T. cruzi genes are intronless (Table 1) . Under stringent PCR conditions, no amplification was obtained whereas, under less stringent conditions, several bands could be obtained with some combinations of primers. However, after sequencing of the amplification products, none of these fragments proved to have any homology with TGF-. We then designed conserved and/or degenerate primers from the alignment of human, bovine, murine and C. elegans TGF-and performed RT-PCR analyses on RNAs from human placenta and murine adrenal glands and PCR analyses on T.cruzi DNA (Table 1) 
T. cruzi can take up exogenous TGF-:
We then tried to check whether T. cruzi amastigotes could bind and internalize exogenous TGF- An experimental model allowing to produce T. cruzi amastigotes under host cell-free conditions has been described: acidic pH treatment of trypomastigotes collected either from the supernatant of infected mammalian cells or from the blood of infected mice induces amastigogenesis and yields viable and proliferating amastigotes 16, 22 . Blood trypomastigotes were acid-induced in vitro to differentiate into amastigotes and these were incubated with biotinylated TGF-for 1 hour at 4°C. After extensive washes, the parasites were incubated with streptavidin-FITC and analyzed by flow cytometry. In parallel, some preparations were eventually further incubated at 37°C to allow internalization, then fixed, spread on a glass slide and observed under a confocal microscope. Flow cytometry analysis of amastigotes permitted the design of an unambiguous window containing parasites (polygon in (Fig. 4E) . Confocal deconvolution of the images confirmed that the fluorescence was intracellular but, due to the extreme flatness of the fixed axenic amastigotes, it was impossible to discern intraparasitic structures.
No staining was observed when the parasites were incubated with biotin instead of biotinylated TGF- (Fig. 4For with streptavidin-FITC alone (Fig. 4G ). This prompted us to conclude that axenic amastigotes are able to bind and internalize exogenous TGF-.
T. cruzi TGF- immunoreactivity is modulated during the intracellular parasite cycle:
We then wondered whether T. cruzi parasites were constantly immunoreactive for TGF- during the intracellular parasitic cycle. Cultures of infected cardiomyocytes were fixed at various periods of time post-infection and TGF- immunoreactivity (stained with anti-TGF--FITC) was imaged by piling up confocal microscopy images. The cells were stained for actin using phalloidin-TRITC in order to visualize the host cell architecture in red. Image processing using a threshold value for eliminating background FITC fluorescence confirmed the localization in the parasite cytoplasm and the specificity of the TGF- staining (shown in light blue Fig. 5C,F,I ). At 24 hours and 48 hours, the parasites were mainly amastigotes as characterized by DAPI staining (Fig. 5A,D) and were intensely stained for TGF- (Fig.   5B ,C,E,F. As shown in the insert of Fig. 5E , the pattern of staining appeared cytoplasmic with the location of the nucleus appearing as a "black hole" (as already noted in Figs 1F,G) .
At 72 hours, TGF- staining was still strong, but more heterogeneous (Fig. 5H,I ), indicating a progressive decrease of TGF- immunoreactivity. This decrease was much more pronounced at 96 hours, when differentiation to trypomastigote was complete as shown by DAPI staining (Fig. 5J, arrows) and only a faint staining remained detectable (Fig. 5K,L, arrows) . Specificity of the TGF- labeling was confirmed by absence of staining in negative controls that were treated with non-immune serum and FITC-labeled secondary antibodies (data not shown).
Image processing of the original immunofluorescence micrographies allowed a better view of the changes in TGF-reactivity in the parasites during the intracellular cycle (Fig. 5C ,F,I,L) and confirmed the dramatic decrease in TGF-immunoreactivity during the transition of amastigotes toward trypomastigotes.
To further illustrate this transition, we analyzed intraparasitic immunoreactivity in cardiomyocytes that were infected for 72 hours and contained parasites at different stages of development. The cell shown in Fig. 6A (shown in higher magnification in Fig. 6C ,E,G,I) contained parasites that were heterogeneously immunoreactive for TGF-. DAPI staining of parasite DNA (Fig. 6B , shown at higher magnification in Fig. 6D ,F,H,J) allowed to recognize amastigotes (yellow circles, Fig. 6C ,D,E,F) from transitional forms (orange ellipses, Fig.   6C ,D,G,H) and trypomastigotes (purple ellipses, Fig. 6C ,D,I,J). TGF-immunoreactivity was strong in all amastigotes, weak in all trypomastigotes and either strong, mild or weak in the transitional forms. As all these forms co-existed in the same cardiomyocyte, it can be concluded that the loss of TGF- immunoreactivity is not dependent on changes in the host cell cytoplasm but is rather an intrinsic response of the parasite associated with cycle progression from amastigote to trypomastigote.
TGF induces amastigote growth inhibition:
The progressive decrease of TGF-immunoreactivity observed during the amastigotetrypomastigote transition is concomitant with the arrest of intracellular parasite proliferation.
As TGF-is a well established growth inhibitor for a number of mammalian cell types 23 ,
we wondered whether it could have a similar effect on T. cruzi amastigotes. We measured the proliferation of axenic amastigotes for 24 and 48h, in the presence or absence of recombinant TGF-1 ( Table 2 ). The results from three different experiments showed that, under control conditions, the parasite population doubled between 24 hours and 48 hours (ratio 48/24h = 1.9 ± 0.2), whereas in the presence of 10 ng/ml TGF-1, the growth was markedly reduced (ratio 48/24h = 1.3 ± 0.1). This difference was statistically significant (p=0.05) and was emphasized (p=0.007) by the effect of neutralizing the cytokine with anti-TGF-. This halt in proliferation was not due to parasite cell death, since parasite motility was sustained and vital labeling with propidium iodide did not show any important modification (data not shown).
Discussion:
The present results strongly suggest that the protozoan Trypanosoma cruzi takes up TGF- from its mammalian host cell, captures it through its cytostome in the flagellar pocket and concentrates it in intracellular vesicles during specific stages of its intracellular cycle. cruzi amastigotes through binding to specific receptors 36,37 .
The novel role of host cell TGF- described herein, adds complexity to T. cruzi biology and discloses additional functions for this cytokine in Chagas disease. TGF-thus appears : (i) to be generated at the host cell surface via parasite-mediated activation of latent TGF- 38 , (ii) to induce downstream signaling along the host cell TGF- receptor pathway thereby favoring cell invasion 11, 12 , (iii) to be taken up intracellularly by the parasites and to control differentiation from amastigotes into trypomastigotes (present study), and (iv) to trigger fibrosis in Chagas cardiomyopathy 4, 5, 10, 13, 14 . 
